Angi Inc.Giá lên
Angi's List | ANGI | Long at $2.00
The historical simple moving average (SMA) I've selected for Angi Inc ANGI is starting to enter stock price. This often means a directional change in price: up in this case. The price drop after the last earnings, I believe, was an algorithmic move for price entry/further consolidation. If true, the two large gaps above may be filled "soon". 70M float, 12% short interest...
Fundamentally, Angi maintains a solid financial foundation with $395 million in cash and cash equivalents. The company's free cash flow increased $29.2 million to $78.4 million for the first nine months of 2024, demonstrating strong cash generation capabilities. The company's transition to a consumer choice model, already successful in its European operations, positions Angi to capture greater market share. Despite revenue headwinds, Angi demonstrates robust financial health with operating income increasing to $7.8 million in third-quarter 2024, a significant improvement from the previous year. The company's adjusted EBITDA grew 27% to $35.4 million, while year-to-date operating income reached $20 million with adjusted EBITDA rising 47% to $114 million, showcasing effective cost management and improving operational efficiency.
Thus at $2.00,ANGI is in a personal buy zone.
Target #1 = $2.25
Target #2 = $2.50
Target #3 = $3.00
Target #4 = $3.50
Target #5 = $3.70
ANGI is starting to enter stock price. This often means a directional change in price: up in this case. The price drop after the last earnings, I believe, was an algorithmic move for price entry/further consolidation. If true, the two large gaps above may be filled "soon". 70M float, 12% short interest...Fundamentally, Angi maintains a solid financial foundation with $395 million in cash and cash equivalents. The company's free cash flow increased $29.2 million to $78.4 million for the first nine months of 2024, demonstrating strong cash generation capabilities. The company's transition to a consumer choice model, already successful in its European operations, positions Angi to capture greater market share. Despite revenue headwinds, Angi demonstrates robust financial health with operating income increasing to $7.8 million in third-quarter 2024, a significant improvement from the previous year. The company's adjusted EBITDA grew 27% to $35.4 million, while year-to-date operating income reached $20 million with adjusted EBITDA rising 47% to $114 million, showcasing effective cost management and improving operational efficiency.
Thus at $2.00,
ANGI is in a personal buy zone.Target #1 = $2.25
Target #2 = $2.50
Target #3 = $3.00
Target #4 = $3.50
Target #5 = $3.70
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.